Wex Pharmaceuticals Inc. Announces Manufacturing Inspection Report

VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - March 27, 2006) - WEX Pharmaceuticals Inc. ("WEX" or the "Company") (TSX:WXI) is pleased to announce that it has received the results of an inspection of its manufacturing plant in China. This inspection was performed by an independent research organization at the request of our co-development partner, Laboratorios del Dr. Esteve S.A., to ensure that the facilities met GMP (Good Manufacturing Practices) requirements.

Back to news